Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in pediatric brain tumor surgery
RBR-863mw5zPhase 3Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in central nervous system tumor (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Need for blood transfusion. Started Apr 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on RBR-863mw5z.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-863mw5z.